FindTrial
Sign In

amlapitta management with Abhayadi Vati

Etio pathological study of Kaphaja Amlapitta and its management by Abhayadi Vati

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/03/017993
Enrollment
60
Registered
2019-03-08
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K319- Disease of stomach and duodenum, unspecified

Interventions

Intervention1: Abhayadi Vati: 4 Tab Twice in a day foir one month Control Intervention1: NIL: NIL

Sponsors

Institute for Post graduate Teaching and Research in Ayurveda Gujarat Ayurved University
Lead Sponsor
DR D H PANDYA
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: WILLING TO PARTICIPATE AGE BETWEEN 18 TO 60 YEAR PATIENTS HAVING SYMPTOMS OF KAPHAJA AMLAPITTA

Exclusion criteria

Exclusion criteria: BELOW 18 YEARS AND ABOVE 60 YEARS OF AGE SUBJECT SUFFERING GIT DISORDERS OTHER THEN KAPHAJA AMLAPITTA 1 PEPTIC ULCER 2 DUODENAL ULCER 3 PANCREATIC AND HEPATIC DISEASE 4 INFLAMATORY BOWEL DISEASE 5 MALIGANCY OF GIT ANY SYSTEMIC DISEASE DM UNCONTROL HTN PATIENTS TAKINGS NASIDs NOT WILLING TO PATIENTS

Design outcomes

Primary

MeasureTime frame
assesment will be done after one month Relief in amlapitta symptomsTimepoint: Relief in amlapitta symptoms—

Secondary

MeasureTime frame
assess will be done after one month Relief in symptoms of kaphaja amlapittaTimepoint: Relief in symptoms of kaphaja amlapitta—

Countries

India

Contacts

Public ContactDr Sandeep raman

Institute for post graduate Teaching and Research in Ayurveda

anup_thakar@yahoo.com9427776660

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026